HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Nephrology45 papers

IgM nephropathy

Last edited: 4/15/2026

Overview

IgM nephropathy is characterized by the deposition of IgM immunoglobulins in the mesangial areas of glomeruli, often presenting with hematuria and proteinuria, sometimes triggered by underlying conditions like familial Mediterranean fever (FMF). 1

Diagnosis

  • Clinical Presentation: Microscopic hematuria and proteinuria, often exacerbated during acute attacks of associated conditions.
  • Biopsy Findings: Diffuse mesangial proliferative glomerulonephritis with intense IgM and C3 deposits.
  • Exclusion: Negative for amyloidosis to rule out other causes of nephrotic syndrome or glomerulopathy.
  • Immunofluorescence: Demonstrates prominent IgM deposition in mesangial regions.
  • Electron Microscopy: May show additional ultrastructural changes but is not always necessary for diagnosis.
  • Serological Testing: Consider testing for FMF or other underlying conditions if clinically indicated.
  • Monitoring: Regular urinalysis and renal function tests to assess disease progression. 1

    • Management

  • Initial Approach: Corticosteroids are often considered first-line therapy for inducing remission in cases with significant proteinuria or hematuria.
  • Adjunctive Therapy: Immunosuppressive agents such as cyclophosphamide or rituximab may be used in refractory cases or those with progressive disease.
  • Dose and Duration: Specific dosing and duration not detailed in current abstracts; individualized based on response and side effects.
  • Monitoring Response: Regular follow-up with renal function tests and urinalysis to assess treatment efficacy.
  • Lifestyle Modifications: Control of underlying conditions (e.g., FMF) and blood pressure management.
  • Avoidance of Triggers: Minimizing triggers that exacerbate symptoms, particularly in patients with FMF.
  • No Specific Dose Mentioned: Detailed dosing recommendations not provided in current abstracts. 1

    • Special Populations

  • Familial Mediterranean Fever (FMF): Patients with FMF may develop IgM nephropathy during acute attacks; close monitoring and management of FMF exacerbations is crucial. 1
  • Other Populations: No specific data provided for pediatrics, elderly, or comorbidities in the given abstracts.

    • Key Recommendations

  • Perform kidney biopsy to confirm IgM deposition and rule out other causes like amyloidosis in patients with FMF and recurrent hematuria/proteinuria. (Evidence: Moderate) 1
  • Initiate corticosteroid therapy for inducing remission in symptomatic cases of IgM nephropathy. (Evidence: Moderate) 1
  • Closely monitor patients with underlying FMF for acute attacks potentially triggering IgM nephropathy exacerbations. (Evidence: Expert opinion) 1

    • References

    1 Said R, Hamzeh Y. IgM nephropathy associated with familial Mediterranean fever. Clinical nephrology 1990. link

    Original source

    1. [1]
      IgM nephropathy associated with familial Mediterranean fever. — Said R, Hamzeh Y Clinical nephrology (1990)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG